In the News - News
"This is the first study to identify a regionally specific diet pattern that is highly associated with adverse outcomes among persons with kidney disease," said lead author Orlando Gutiérrez, MD, Associate Professor of Medicine at the University of Alabama at Birmingham. "It's well known that the Southern region has poor health outcomes in a number of different areas including stroke, heart disease and sepsis, and that the style of diet plays a role."
Joy P. Deupree, an assistant professor, has been named one of only 20 Robert Wood Johnson Foundation Executive Nurse Fellows in the United States for 2014, according to a news release on Wednesday from the Foundation. Maria R. Shirey, a professor and assistant dean for Clinical Affairs and Partnerships in the School of Nursing, has been selected for induction as a fellow in the National League for Nursing (NLN) Academy of Nursing Education,
A new study has good news: The easiest and most obvious intervention—making texting while driving illegal—works. Traffic fatalities dropped 3 percent in states that allow police to pull over drivers for texting, according to new research from the American Journal of Public Health.
Elementary and high school students and their parents who wish to learn more about the importance of the much-hyped STEM disciplines – science, technology, engineering and math – can attend the STEM Awareness Forum to be held in Bessemer tonight.
"We have a broader array of workers than you'd see in other cities, from hourly employees in mining and manufacturing to CEOs of biotech firms," says Jack Howard, Ph.D., associate dean at the University of Alabama at Birmingham's Collat School of Business. "It's a laid-back culture, but there's a very strong work ethic."
There are a lot of regimens being tried in transplant, and most include calcineurin inhibitors that have significant toxicity," Anupam Agarwal, MD, of the University of Alabama at Birmingham, told MedPage Today. "Hence, if one could safely reduce the dose of the calcineurin inhibitor and still benefit from its immunosuppressive properties, it would be huge advance."
The UAB Cancer Center was selected as one of 30 cancer centers in the nation, and one of only five in the Southeast. The five-year grant, which awards $497,800 annually, allows the Cancer Center to be part of NCI's primary infrastructure to conduct state-of-the-art cancer treatment and advanced imaging clinical trials, especially large, definitive multi-institutional trials evaluating new cancer therapies and related clinical approaches for both adult and pediatric patients.
“MitraClip therapy is a groundbreaking treatment for mitral regurgitation, which is the most common type of heart valve insufficiency,” said Oluseun Alli, M.D., director of the structural heart program in the UAB School of Medicine Section of Interventional Cardiology. “This device is currently the only minimally invasive treatment we have for these high-risk patients, and it is the only device that has been effective in treating severe mitral regurgitation apart from open surgical repair or replacement.
“Very little is known about whether laws banning texting while driving have actually improved roadway safety,” UAB's Dr. Alva Ferdinand said. “Further, given the considerable variation in the types of laws that states have passed and whom they ban from what, it was necessary to determine which types of laws are most beneficial in improving roadway safety.”
"They're getting the experience they need to get plugged into that whole cyber security realm and maybe go work for Facebook," Director of UAB's "The Center" Dr. John Sloan said. "So we have folks that are working on developing new tools. We also have folks who are taking existing tools and then applying them in innovative ways to address cybersecurity issues."
More than 90 new Woodlawn High School 9th and 10th graders will get their school year off to a good start this week by taking part in special learning activities planned for them on the campuses of The University of Alabama at Birmingham (UAB) and Lawson State Community College.
As kids prepare to head back to school, required immunizations are typically on the to-do list, but getting potentially lifesaving vaccines should not end when adulthood begins, says one University of Alabama at Birmingham infectious diseases expert.
effrey R. Curtis, M.D., from the University of Alabama at Birmingham, and colleagues utilized 1998 to 2011 data from the U.S. Veterans Health Administration to identify RA patients initiating rituximab, abatacept, or anti-tumor necrosis factor (anti-TNF) therapy. The authors sought to assess the comparative risk of hospitalized infection associated with anti-TNF and non-anti-TNF biologic agents.